FDA Drug Application (017561) for CELESTONE by SCHERING

Back to FDA Applications sponsored by SCHERING

Application Number017561
Product Number001
FormINJECTABLE;INJECTION
DosageEQ 3MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCELESTONE
Active IngredientBETAMETHASONE SODIUM PHOSPHATE

Active IngredientCount
List of drugs with Active Ingredient BETAMETHASONE SODIUM PHOSPHATE4


Back to FDA Applications sponsored by SCHERING